PARIET Side Effects

6065276-6 | Cholestasis, Hepatic Function Abnormal
on Jan 26, 2009 Male patient from JAPAN , 79 years of age, was treated with Pariet (View Usage). Patient experienced the following unwanted or unexpected effects: cholestasis, hepatic function abnormal. Pariet dosage: Unk. During the same period patient was treated with LASIX (Unk) (View Lasix Review and Lasix Label ), ASPIRIN (Unk) (View Aspirin Review and Aspirin Label ), SIGMART (Unk) (View Sigmart Review and Sigmart Label ), OLMETEC (Unk) (View Olmetec Review and Olmetec Label ), ARTIST (Unk) (View Artist Review and Artist Label ), WARFARIN POTASSIUM (Unk) (View Warfarin Potassium Review and Warfarin Potassium Label ), ZYLORIC (Unk) (View Zyloric Review and Zyloric Label ), PLAVIX (Unk) (View Plavix Review and Plavix Label ).

5730106-6 | Arthralgia, Blood Calcium Increased, Bone Marrow Leukaemic Cell Infiltration, Bone Pain, Cellulitis, Fasciitis, Gait Disturbance, Haematocrit Decreased, Haematoma
Patient was taking Pariet (View Usage). Patient had the following side effects: arthralgia, blood calcium increased, bone marrow leukaemic cell infiltration, bone pain, cellulitis (What is cellulitis?), fasciitis, gait disturbance, haematocrit decreased, haematoma on Apr 22, 2008 from JAPAN Additional patient health information: Male patient , 68 years of age, weighting 143.3 lb, was diagnosed with chronic myeloid leukaemia and. Pariet dosage: 20 Mg. During the same period patient was treated with MUCOSTA (300 Mg) (View Mucosta Review and Mucosta Label ), GLEEVEC (400 Mg, Qd) (View Gleevec Review and Gleevec Label ). Patient was hospitalized.

5729823-3 | Arthralgia, Blood Calcium Increased, Bone Marrow Leukaemic Cell Infiltration, Bone Pain, Cellulitis, Fasciitis, Gait Disturbance, Haematocrit Decreased, Haematoma
Adverse event was reported on Apr 22, 2008 by a Male patient taking Pariet (View Usage) (Dosage: 20 Mg) was diagnosed with chronic myeloid leukaemia and. Location: JAPAN , 68 years of age, weighting 143.3 lb, After Pariet was administered, patient had the following side effects: arthralgia, blood calcium increased, bone marrow leukaemic cell infiltration, bone pain, cellulitis (What is cellulitis?), fasciitis, gait disturbance, haematocrit decreased, haematoma. During the same period patient was treated with MUCOSTA (300 Mg) (View Mucosta Review and Mucosta Label ), GLEEVEC (400 Mg, Qd) (View Gleevec Review and Gleevec Label ). Patient was hospitalized.

5729397-7 | Arthralgia, Blood Calcium Increased, Bone Marrow Leukaemic Cell Infiltration, Bone Pain, Cellulitis, Fasciitis, Gait Disturbance, Haematocrit Decreased, Haematoma
on Apr 22, 2008 Male patient from JAPAN , 68 years of age, weighting 143.3 lb, was diagnosed with chronic myeloid leukaemia and was treated with Pariet (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, blood calcium increased, bone marrow leukaemic cell infiltration, bone pain, cellulitis (What is cellulitis?), fasciitis, gait disturbance, haematocrit decreased, haematoma. Pariet dosage: 20 Mg. During the same period patient was treated with MUCOSTA (300 Mg) (View Mucosta Review and Mucosta Label ), GLEEVEC (400 Mg, Qd) (View Gleevec Review and Gleevec Label ). Patient was hospitalized.


5657912-0 | Arthralgia, Blood Calcium Increased, Bone Marrow Leukaemic Cell Infiltration, Bone Pain, Cellulitis, Fasciitis, Gait Disturbance, Haematocrit Decreased, Haematoma
on Feb 27, 2008 Male patient from JAPAN , 68 years of age, weighting 143.3 lb, was diagnosed with chronic myeloid leukaemia and was treated with Pariet (View Usage). Patient had the following side effects: arthralgia, blood calcium increased, bone marrow leukaemic cell infiltration, bone pain, cellulitis (What is cellulitis?), fasciitis, gait disturbance, haematocrit decreased, haematoma. Pariet dosage: 20 Mg. During the same period patient was treated with MUCOSTA (300 Mg) (View Mucosta Review and Mucosta Label ), GLEEVEC (400 Mg/day) (View Gleevec Review and Gleevec Label ). Patient was hospitalized.

5639040-3 | Ventricular Tachycardia
Patient was taking Pariet (View Usage). After Pariet was administered, patient had the following side effects: ventricular tachycardia on Feb 21, 2008 from JAPAN Additional patient health information: Male patient , weighting 123.5 lb, was diagnosed with chest discomfort, hypertension and. Pariet dosage: 10 Mg. During the same period patient was treated with MAGMITT (View Magmitt Review and Magmitt Label ), BULKOSE (View Bulkose Review and Bulkose Label ), SPIRIVA (18 Mcg) (View Spiriva Review and Spiriva Label ), FLUTIDE (View Flutide Review and Flutide Label ), SEREVENT (View Serevent Review and Serevent Label ), MEILAX (2 Mg) (View Meilax Review and Meilax Label ), CARDENALIN (2 Mg) (View Cardenalin Review and Cardenalin Label ).

5303125-1 | Abdominal Pain, Dehydration, Diarrhoea, Flatulence, Malaise, Mouth Ulceration, Oedema Mouth, Oral Discomfort, Oral Pain
Adverse event was reported on Apr 11, 2007 by a Female patient taking Pariet (View Usage) (Dosage: 1 Tablet In The Morning) was diagnosed with reflux oesophagitis, constipation (What is constipation?) and. Location: BRAZIL , 46 years of age, weighting 143.3 lb, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), dehydration, diarrhoea, flatulence, malaise, mouth ulceration, oedema mouth, oral discomfort, oral pain. During the same period patient was treated with ZELMAC (1 Tablet Every 12 Hours) (View Zelmac Review and Zelmac Label ).

5294575-0 | Abdominal Pain, Dehydration, Diarrhoea, Flatulence, Malaise, Mouth Ulceration, Oedema Mouth, Oral Discomfort, Oral Pain
on Mar 29, 2007 Female patient from BRAZIL , 46 years of age, weighting 143.3 lb, was diagnosed with reflux oesophagitis, constipation (What is constipation?) and was treated with Pariet (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), dehydration, diarrhoea, flatulence, malaise, mouth ulceration, oedema mouth, oral discomfort, oral pain. Pariet dosage: 1 Tablet In The Morning. During the same period patient was treated with ZELMAC (2 Tablet Every 12 Hours) (View Zelmac Review and Zelmac Label ).

5289547-6 | Abdominal Pain, Dehydration, Diarrhoea, Flatulence, Malaise, Mouth Ulceration, Oedema Mouth, Oral Discomfort, Oral Pain
on Mar 26, 2007 Female patient from BRAZIL , 46 years of age, weighting 143.3 lb, was diagnosed with reflux oesophagitis, constipation (What is constipation?) and was treated with Pariet (View Usage). After Pariet was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), dehydration, diarrhoea, flatulence, malaise, mouth ulceration, oedema mouth, oral discomfort, oral pain. Pariet dosage: 1 Tablet In The Morning. During the same period patient was treated with ZELMAC (2 Tablet Every 12 Hours) (View Zelmac Review and Zelmac Label ).

5166487-4 | Back Injury, Back Pain, Cranial Nerve Paralysis, Dysarthria, Fall, Hemiplegia, Lumbar Vertebral Fracture, Thrombotic Stroke
Patient was taking Pariet (View Usage). Patient experienced the following unwanted or unexpected effects: back injury, back pain (What is back pain?), cranial nerve paralysis, dysarthria, fall (What is fall?), hemiplegia, lumbar vertebral fracture, thrombotic stroke on Dec 01, 2004 from JAPAN Additional patient health information: Female patient , 73 years of age, weighting 99.21 lb, was diagnosed with reflux oesophagitis, enterocolitis, anaemia, hypertension, cerebral thrombosis, constipation (What is constipation?) and. Pariet dosage: . During the same period patient was treated with BIOFERMIN (View Biofermin Review and Biofermin Label ), FERROMIA (View Ferromia Review and Ferromia Label ), ATELEC (View Atelec Review and Atelec Label ), TANATRIL (Unk, Unk) (View Tanatril Review and Tanatril Label ), ASPIRIN (Unk, Unk) (View Aspirin Review and Aspirin Label ), MAGLAX (Unk, Unk) (View Maglax Review and Maglax Label ), DIOVAN (Unk, Unk) (View Diovan Review and Diovan Label ). Patient was hospitalized and became disabled.

5029043-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Creatine Phosphokinase Increased, Blood Lactate Dehydrogenase Increased, Blood Urea Increased, Catheterisation Cardiac, Chest Pain, Gamma-glutamyltransferase Increased
Adverse event was reported on May 31, 2006 by a Female patient taking Pariet (View Usage) (Dosage: 10 Mg/day) was diagnosed with reflux oesophagitis, hypercholesterolaemia, constipation (What is constipation?), osteoporosis (What is osteoporosis?), thoracic vertebral fracture and. Location: JAPAN , 81 years of age, Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, blood urea increased, catheterisation cardiac, chest pain (What is chest pain?), gamma-glutamyltransferase increased. During the same period patient was treated with LOCHOL (30 Mg/day) (View Lochol Review and Lochol Label ), LAXOBERON (View Laxoberon Review and Laxoberon Label ), PERSENNID (Unk, Unk) (View Persennid Review and Persennid Label ), ACTONEL (2.5 Mg/day) (View Actonel Review and Actonel Label ), VOLTAREN (50 Mg/day) (View Voltaren Review and Voltaren Label ). Patient was hospitalized.

4801116-8 | Anaemia Haemolytic Autoimmune, Depression, Pneumonia
on Sep 28, 2005 Female patient from JAPAN , 88 years of age, was diagnosed with reflux oesophagitis, hypertension and was treated with Pariet (View Usage). After Pariet was administered, patient had the following side effects: anaemia haemolytic autoimmune, depression (What is depression?), pneumonia (What is pneumonia?). Pariet dosage: 10 Mg/day. During the same period patient was treated with DIOVAN (80 Mg/day) (View Diovan Review and Diovan Label ). Patient was hospitalized.

4785911-X | Anaemia Haemolytic Autoimmune, Depression, Pneumonia
on Sep 28, 2005 Female patient from JAPAN , 88 years of age, was diagnosed with reflux oesophagitis, hypertension and was treated with Pariet (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia haemolytic autoimmune, depression (What is depression?), pneumonia (What is pneumonia?). Pariet dosage: 10 Mg/day. During the same period patient was treated with DIOVAN (80 Mg/day) (View Diovan Review and Diovan Label ). Patient was hospitalized.

4744727-0 | Anuria, Oral Intake Reduced, Renal Failure Acute
Patient was taking Pariet (View Usage). Patient had the following side effects: anuria, oral intake reduced, renal failure acute on Jul 26, 2005 from JAPAN Additional patient health information: Female patient , 81 years of age, was diagnosed with reflux oesophagitis and. Pariet dosage: . During the same period patient was treated with SELBEX (View Selbex Review and Selbex Label ), DIOVAN (View Diovan Review and Diovan Label ), EPADEL (View Epadel Review and Epadel Label ), GANATON (View Ganaton Review and Ganaton Label ).